Nguyen, T.-M.; Ngo, T.-H.; Truong, A.-Q.; Vu, D.-H.; Le, D.-C.; Vu, N.-B.; Can, T.-N.; Nguyen, H.-A.; Phan, T.-P.; Van Bambeke, F.;
et al. Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Pharmaceutics 2021, 13, 456.
https://doi.org/10.3390/pharmaceutics13040456
AMA Style
Nguyen T-M, Ngo T-H, Truong A-Q, Vu D-H, Le D-C, Vu N-B, Can T-N, Nguyen H-A, Phan T-P, Van Bambeke F,
et al. Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Pharmaceutics. 2021; 13(4):456.
https://doi.org/10.3390/pharmaceutics13040456
Chicago/Turabian Style
Nguyen, Thu-Minh, Thu-Hue Ngo, Anh-Quan Truong, Dinh-Hoa Vu, Dinh-Chi Le, Ngan-Binh Vu, Tuyet-Nga Can, Hoang-Anh Nguyen, Thu-Phuong Phan, Françoise Van Bambeke,
and et al. 2021. "Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease" Pharmaceutics 13, no. 4: 456.
https://doi.org/10.3390/pharmaceutics13040456
APA Style
Nguyen, T. -M., Ngo, T. -H., Truong, A. -Q., Vu, D. -H., Le, D. -C., Vu, N. -B., Can, T. -N., Nguyen, H. -A., Phan, T. -P., Van Bambeke, F., Vidaillac, C., & Ngo, Q. -C.
(2021). Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Pharmaceutics, 13(4), 456.
https://doi.org/10.3390/pharmaceutics13040456